Roles of avian herpesvirus microRNAs in infection, latency, and oncogenesis

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 11-12, 2011, Pages 654-659

  Morgan, Robin W ^a   Burnside, Joan ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

Avian herpesvirus; Herpesvirus microRNAs; Herpesvirus of turkeys; Marek's disease virus

Indexed keywords

MICRORNA;

ARTICLE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCATION; GENETIC CONSERVATION; GENETIC VARIABILITY; HERPES VIRUS; HERPES VIRUS INFECTION; HERPESVIRUS OF TURKEY; ILTOVIRUS; MARDIVIRUS; NONHUMAN; OPEN READING FRAME; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE HOMOLOGY; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS ISOLATION; VIRUS LATENCY; VIRUS VIRULENCE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; GENOME, VIRAL; HERPESVIRUS 2, GALLID; MICRORNAS; PHYLOGENY; TURKEYS; VIRUS LATENCY;

AVES; GALLID HERPESVIRUS 1; GALLID HERPESVIRUS 2; HERPESVIRIDAE; MELEAGRID HERPESVIRUS 1;

EID: 80655127825     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2011.06.001     Document Type: Article

References (51)

1. Roizman B. Herpesviridae. Virology 1996, 2221-2230. Lippincott-Raven Publishers, Philadelphia. D.M.K., B.N. Fields, P.M. Howley, R.M. Chanaock, J.L. Melnick, T.P. Monath, B. Roizman, S.E. Straus (Eds.).
2. McGeoch D.J., Rixon F.J., Davison A.J. Topics in herpesvirus genomics and evolution. Virus Res. 2006, 117:90-104.
3. Purchase H.G. Clinical disease and its economic impact. Marek's Disease 1985, 17-42. Martinus Nijhoff Publishing, Boston. L.N. Payne (Ed.).
4. Burnside J., Bernberg E., Anderson A., Lu C., Meyers B.C., Green P.J., Jain N., Isaacs G., Morgan R.W. Marek's disease virus encodes microRNAs that map to meq and the latency-associated transcript. J. Virol. 2006, 80:8778-8786.
5. Aird D., Ross M.G., Chen W.S., Danielsson M., Fennell T., Russ C., Jaffe D.B., Nusbaum C., Gnirke A. Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries. Genome Biol. 2011, 12.
6. Yao Y., Zhao Y., Xu H., Smith L.P., Lawrie C.H., Watson M., Nair V. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs. J. Virol. 2008, 82:4007-4015.
7. Hayward W.S., Neel B.G., Astrin S.M. Activation of a cellular oncogene by promoter insertion in ALV-induced lymphoid leukosis. Nature 1999, 290:475-480.
8. Gottwein E., Mukherjee N., Sachse C., Frenzel C., Majoros W.H., Chi J.-T.A., Braich R., Manoharan M., Soutschek J., Ohler U., Cullen B.R. A viral microRNA functions as an orthologue of cellular miR-155. Nature 2007, 450:1096-1099.
9. Skalsky R.L., Samols M.A., Plaisance K.B., Boss I.W., Riva A., Lopez M.C., Baker H.V., Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 2007, 81:12836-12845.
10. Zhao Y., Yao Y., Xu H., Lambeth L., Smith L.P., Kgosana L., Wang X., Nair V. A functional microRNA-155 ortholog encoded by the oncogenic Marek's Disease Virus. J. Virol. 2009, 83:489-492.
11. Morgan R., Anderson A., Bernberg E., Kamboj S., Huang E., Lagasse G., Isaacs G., Parcells M., Meyers B.C., Green P.J., Burnside J. Sequence conservation and differential expression of Marek's disease virus microRNAs. J Virol. 2008, 82:12213-12220.
12. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., van Dongen S., Grocock R.J., Das P.P., Miska E.A., Vetrie D., Okkenhaug K., Enright A.J., Dougan G., Turner M., Bradley A. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
13. Tam W., Hughes S.H., Hayward W.S., Besmer P. Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J. Virol. 2002, 76:4275-4286.
14. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., Croce C.M. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E mu-miR155 transgenic mice. PNAS 103:7024-7029. PNAS 2006, 103:7024-7029.
15. O'Connell R.M., Rao D.S., Chaudhuri A.A., Boldin M.P., Taganov K.D., Nicoll J., Paquette R.L., Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J. Exp. Med. 2008, 205:585-594.
16. Yao Y., Zhao Y., Xu H., Smith L.P., Lawrie C.H., Sewer A., Zavolan M., Nair V. Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. J. Virol. 2007, 81:7164-7170.
17. Waidner L.A., Morgan R.W., Anderson A.S., Bernberg E.L., Kamaboj S., Garcia M., Riblet S.M., Ouynag M., Isaacs G.K., Markis M., Meyers B.C., Green P.J., Burnside J. MicroRNAs of Gallid and Meleagrid herpesviruses show generally conserved genomic locations and are virus specific. Virology 2009, 388:128-136.
18. Garzon R., Heaphy C.E.A., Havelange V., Fabbri M., Volinia S., Tsao T., Zanesi N., Kornblau S.M., Marcucci G., Calin G.A., Andreeff M., Croce C.M. MicroRNA 29b functions in acute myeloid leukemia. Blood 2009, 114:5331-5341.
19. Yao Y., Zhao Y., Smith L.P., Watson M., Nair V. Novel microRNAs (miRNAs) encoded by herpesvirus of turkeys: evidence of miRNA evolution by duplication. J. Virol. 2009, 83:6969-6973.
20. Burnside J., Morgan R.W., Green P.J., Meyers B.C., Nobuta K., Kamboj S., Gupta R., McCormick K., Shridhara G., Nakano M., Hetawal A., Valliappan R.M. Gallus gallus sbs http://mpss.udel.edu/gga/,website.
21. Burnside J., Ouyang M., Anderson A., Bernberg E., Lu C., Meyers B.C., Green P.J., Markis M., Isaacs G.K., Huang E., Morgan R.W. Deep sequencing of chicken microRNAs. BMC Genomics 2008, 9. 10.1186/1471-2164-1189-1185.
22. Niikura M., Dodgson J., Cheng H. Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. Arch. Virol. 2006, 151:537-549.
23. Galardi S., Mercatelli N., Giorda E., Massalini S., Frajese G.V., Ciafre S.A., Farace M.G. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 2007, 282:23716-23724.
24. Huleatt J.W., Cresswell J., Bottomly K., Crispe I.N. P27(kip1) regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal. Immunology 2003, 108:493-501.
25. Li W.Q., Jiang Q., Aleem E., Kaldis P., Khaled A.R., Durum C.K. IL-7 promotes T cell proliferation through destabilization of p27Kip1. J. Exp. Med. 2006, 203:576-582.
26. Lambeth L.S., Yao Y., Smith L.P., Zhao Y., Nair V. MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1. J. Gen. Virol. 2009, 90:1164-1171.
27. Rachamadugu R., Lee J.Y., Wooming A., Kong B.W. Identification and expression analysis of infectious laryngotracheitis virus encoding microRNAs. Virus Genes 2009, 39:301-308.
28. Waidner L.A., Burnside J., Anderson A.S., Bernberg E.L., German M.A., Meyers B.C., Green P.J., Morgan R.W. A microRNA of infectious laryngotracheitis virus can downregulate and direct cleavage of ICP4 mRNA. Virology 2011, 411:25-31.
29. Xu H., Yao Y., Zhao Y., Smith L.P., Baigent S.J., Nair V. Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR. J. Virol. Methods 2008, 149:201-208.
30. Luo J., Sun A.-J., Teng M., Zhou H., Cui Z.-Z., Qu L.-H., Zhang G.-P. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease. J. Gen. Virol. 2011, 92:608-620.
31. http://mpss.udel.edu/gga/.
32. Thomson J.M., Newman M., Parker J.S., Morin-Kensicki E.M., Wright T., Hammond S.M. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev. 2006, 20:2202-2207.
33. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-843.
34. Cantello J., Anderson A., Morgan R. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus. J. Virol. 1994, 68:6280-6290.
35. Xu Z., Wei W., Gagneur J., Clauder-Munster S., Smolik M., Huber W., Steinmetz L.M. Antisense expression increases gene expression variability and locus interdependency. Mol. Syst. Biol. 2011, 7:468-478.
36. Yao Y., Zhao Y., Smith L.P., Lawrie C.H., Saunders N.J., Watson M., Nair V. Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. J. Gen. Virol. 2009, 90:1551-1559.
37. Meister G., Landthaler M., Dorsett Y., Tuschl T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 2004, 10:544-550.
38. Chen J.-F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.-Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
39. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., MacDonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
40. Muylkens B., Coupeau D., Dambrine G., Trapp S., Rasschaert D. Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes. Arch. Virol. 2010, 155:1823-1837.
41. Xu S., Xue C., Li J., Bi Y., Cao Y. Marek's disease virus type 1 MicroRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting SMAD2 of the transforming growth factor beta signal pathway. J. Virol. 2011, 85:276-285.
42. Zhao Y., Xu H., Yao Y., Smith L.P., Kgosana L., Green J., Petherbridge L., Baigent S.J., Nair V. Critical role of the virus-encoded MicroRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS Pathog 2011, 7:e1001305.
43. Rhoades M.W., Reinhart B.J., Lim L.P., Burge C.B., Bartel B., Bartel D.P. Prediction of plant microRNA targets. Cell 2002, 110:513-520.
44. Enright A., John B., Gaul U., Tuschl T., Sander C., Marks D. MicroRNA targets in Drosophila. Genome Biol. 2003, 5:R1.
45. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
46. Rehmsmeier M., Steffen P., Höchsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
47. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
48. Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4:721726.
49. Gentner B., Schira G., Giustacchini A., Amendola M., Brown B.D., Ponzoni M., Naldini L. Stable knockdown of microRNA in vivo by lentiviral vectors. Nat. Methods 2009, 6:63-66.
50. Xu G., Fewell C., Taylor C., Deng N., Hedges D., Wang X., Zhang K., Lacey M., Zhang H., Yin Q., Cameron J., Lin Z., Zhu D., Flemington E.K. Transcriptome and targetome analysis in MIR155 expressing cells using RNA-seq. RNA 2010, 16:1610-1622.
51. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Jungkamp A.-C., Munschauer M., Ulrich A., Wardle G.S., Dewell S., Zavolan M., Tuschl T. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.